跳转至内容
Merck
CN

1477900

USP

对甲氧基肉桂酸乙基己酯

United States Pharmacopeia (USP) Reference Standard

别名:

4-甲氧基肉桂酸 2-乙基己基酯, OMC, 甲氧肉桂酸辛酯

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C18H26O3
化学文摘社编号:
分子量:
290.40
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
5946632
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

对甲氧基肉桂酸乙基己酯, United States Pharmacopeia (USP) Reference Standard

InChI

1S/C18H26O3/c1-4-6-7-15(5-2)14-21-18(19)13-10-16-8-11-17(20-3)12-9-16/h8-13,15H,4-7,14H2,1-3H3/b13-10+

SMILES string

CCCCC(CC)COC(=O)\C=C\c1ccc(OC)cc1

InChI key

YBGZDTIWKVFICR-JLHYYAGUSA-N

grade

pharmaceutical primary standard

API family

octinoxate

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

正在寻找类似产品? 访问 产品对比指南

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Application

Octinoxate USP reference standard suitable for use in specified USP compendial quality tests and assays.

Also used to prepare standard and system suitability solution during the assay of Octinoxate by using gas chromatography in conjunction with flame ionization detector.

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

hcodes

Hazard Classifications

Aquatic Chronic 4

存储类别

10 - Combustible liquids

wgk

WGK 2

flash_point_f

379.4 °F

flash_point_c

193 °C


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Octinoxate
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(3), 3225-3225 (2020)
Timothy P Murphy et al.
Journal of the American College of Cardiology, 65(10), 999-1009 (2015-03-15)
Treatment for claudication that is due to aortoiliac peripheral artery disease (PAD) often relies on stent revascularization (ST). However, supervised exercise (SE) is known to provide comparable short-term (6-month) improvements in functional status and quality of life. Longer-term outcomes are

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持